An update from Zignago Vetro SpA ( (IT:ZV) ) is now available.
Zignago Vetro S.p.A. has been designated as a remedy taker in the acquisition of Bormioli Pharma by Gerresheimer AG, specifically in the Type 3 soda-lime glass sector for pharmaceuticals. As part of this agreement, Zignago Vetro will acquire Bormioli Pharma’s pharmaceutical customers in Austria and select neighboring countries, ensuring competition remains robust in this market. This strategic move allows Zignago Vetro to expand its product offerings and market presence in regions it already serves, reinforcing its commitment to high-quality service.
More about Zignago Vetro SpA
Zignago Vetro S.p.A. operates in the glass manufacturing industry, focusing on producing glass containers. The company is involved in various sectors, including the pharmaceutical sector, where it provides Type 3 soda-lime glass containers.
YTD Price Performance: 4.57%
Average Trading Volume: 167
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €882.1M
See more data about ZV stock on TipRanks’ Stock Analysis page.